3 Tech Stocks to Buy for the New Year and Hold Through 2030

Nvidia, ASML and Palantir are positioned as primary beneficiaries of the AI infrastructure boom: Nvidia reported fiscal Q3 2026 revenue of $57 billion, up 62% year-over-year and sits at a >$4 trillion valuation while forecasting AI infrastructure could be a $3–4 trillion-a-year market by decade end. ASML, the sole supplier of EUV lithography, posted Q3 revenue of €7.51 billion (~$8.84 billion) with a 51.6% gross margin and €2.12 billion net income, underscoring durable demand for advanced chipmaking tools. Palantir is seeing rapid commercial expansion—U.S. commercial revenue was $397 million (up 121% YoY) versus U.S. government revenue of $486 million (up 52% YoY)—even as its government work draws political scrutiny, supporting a bullish view on their commercial monetization trajectories.

Analysis

Market structure: Nvidia (NVDA) and ASML (ASML) sit on oligopolistic moats — GPUs for data‑center clustering and EUV lithography respectively — which suggests durable pricing power and a multi-year demand curve for capex. Expect concentrated order books: NVDA will continue to command a premium ASP for H100/A100 class GPUs, and ASML will see lumpy but high‑margin order intake; this implies idiosyncratic volatility but structurally tighter supply vs. demand for advanced nodes and AI racks through 2026–2028.

Risk assessment: Tail risks include accelerated export controls (China restrictions on EUV/GPU shipments), a meaningful NVDA competitive breakthrough, or a Palantir (PLTR) regulatory backlash that curtails U.S. government contracts; any of these could erase 20–40% of near‑term enterprise value. Time horizons matter: days–weeks are dominated by order‑intake/earnings beats, months by inventory digestion and capex cadence, and years by fab capacity expansion and model proliferation; monitor NVDA revenue guide and ASML order intake quarterly for >5% deviations.

Trade implications: For directional exposure favor defined‑risk entries: buy NVDA via 3–6 month call spreads sized 2–3% of portfolio to capture near‑term AI momentum while limiting blowups; establish a core 2–4% long in ASML for secular EUV scarcity, with a 12–24 month horizon. Use pair trades to hedge cyclicality: long ASML (3%) / short LRCX (1.5%) to isolate EUV vs DUV/capex risk; size PLTR exposure tiny (≤1%) via LEAP calls or buy‑write to exploit rapid commercial growth but cap political risk.

Contrarian angles: The consensus likely overstates TAM timing — Huang’s $3–4T AI‑infra by 2030 is plausible but front‑loaded expectations may be priced in, creating vulnerability to short‑term misses. Also ASML’s monopoly masks geographic concentration risk (China policy could remove a ~10–20% demand bucket); Palantir’s rising commercial revenue (121% YoY) is underappreciated as a de‑risking vector, suggesting option‑based asymmetric long exposure rather than outright large equity positions.

Key Decisions for Investors

• Establish a defined‑risk NVDA position: allocate 2–3% of portfolio to 3–6 month bull call spreads (buy 1 ATM call, sell 1–1.2x OTM) entered within 2 weeks; if NVDA guidance misses revenue by >5% or shares gap down >15% from entry, close for loss.
• Initiate a core ASML position sized 2.5–4% of portfolio for a 12–24 month hold to capture EUV scarcity; trim 25% if reported order intake falls >20% YoY or if ASML announces >1 quarter delay in EUV shipments to key customers.
• Run a relative‑value pair: long ASML (3% weight) and short LRCX (1.5% weight) to isolate EUV vs DUV/capex exposure; rebalance monthly and cut the short leg if LRCX underperforms by >15% or ASML outperforms by >25%.
• Small asymmetric Palantir exposure: purchase PLTR 12–24 month LEAP calls sized ≤1% of portfolio or buy 3–6 month call spreads to capture commercial growth while limiting regulatory downside; exit if U.S. government revenue share falls <45% of total or if major contracting bans appear within 90 days.
• Use cash‑secured put selling on NVDA to lower entry: sell 30–60 day puts 8–12% OTM sized to convert up to 1–2% of portfolio into long exposure at a lower price; cap assignment risk and avoid net leverage if implied volatility spikes >40%.